APO RESEARCH · REPORT
Peptic Ulcer Drugs
A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.
Product & engineering
Understand the product.
A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.
Selected research
Industry Research
Peptic Ulcer Drugs Industry Research Report 2026
Market perspective
A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from Helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies Peptic Ulcer Drugs market.
The main global Peptic Ulcer Drugs players include Takeda Pharmaceutical, AstraZeneca, Pfizer, Teva Pharmaceuticals, EA Pharma, etc. The top five Peptic Ulcer Drugs players account for approximately 43% of the total market. United States is the largest consumer market for Peptic Ulcer Drugs, accounting for about 30%, followed by Europe and China. In terms of type, Proton Pump Inhibitors is the largest segment, with a share over 68%. And in terms of application, the largest application is Hospital and Clinic, followed by Drugstore.
Report Scope
Read the full market overview
This report quantifies the global Peptic Ulcer Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (M Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptic Ulcer Drugs Market by Company
Takeda Pharmaceutical
AstraZeneca
Pfizer
Teva Pharmaceuticals
EA Pharma
ASK Pharm
Luoxin Pharmaceutical
Abbott Laboratories
Yuhan Pharmaceutical
Daewoong Pharmaceutical
Peptic Ulcer Drugs Segment by Type
Proton Pump Inhibitors
H2-Antagonists
Antacids
Others
Peptic Ulcer Drugs Segment by Application
Hospital and Clinic
Drugstore
Peptic Ulcer Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcer Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcer Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcer Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peptic Ulcer Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peptic Ulcer Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitors
- H2-Antagonists
- Antacids
- Others
Applications
- Hospital and Clinic
- Drugstore
Companies covered
- Takeda Pharmaceutical
- AstraZeneca
- Pfizer
- Teva Pharmaceuticals
- EA Pharma
- ASK Pharm
- Luoxin Pharmaceutical
- Abbott Laboratories
- Yuhan Pharmaceutical
- Daewoong Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Peptic Ulcer Drugs Market Size (2021-2032)
- 2.2.2 Global Peptic Ulcer Drugs Sales (2021-2032)
- 2.2.3 Global Peptic Ulcer Drugs Market Average Price (2021-2032)
- 2.3 Peptic Ulcer Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Proton Pump Inhibitors
- 2.3.3 H2-Antagonists
- 2.3.4 Antacids
- 2.3.5 Others
- 2.4 Peptic Ulcer Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Drugstore
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Peptic Ulcer Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Peptic Ulcer Drugs Sales (M Unit) of Manufacturers (2021-2026)
- 3.3 Global Peptic Ulcer Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Peptic Ulcer Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Peptic Ulcer Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Peptic Ulcer Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Peptic Ulcer Drugs, Product Type & Application
- 3.8 Global Manufacturers of Peptic Ulcer Drugs, Established Date
- 3.9 Global Peptic Ulcer Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceutical
- 4.1.1 Takeda Pharmaceutical Company Information
- 4.1.2 Takeda Pharmaceutical Business Overview
- 4.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 4.1.5 Takeda Pharmaceutical Recent Developments
- 4.2 AstraZeneca
- 4.2.1 AstraZeneca Company Information
- 4.2.2 AstraZeneca Business Overview
- 4.2.3 AstraZeneca Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZeneca Peptic Ulcer Drugs Product Portfolio
- 4.2.5 AstraZeneca Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Peptic Ulcer Drugs Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Teva Pharmaceuticals
- 4.4.1 Teva Pharmaceuticals Company Information
- 4.4.2 Teva Pharmaceuticals Business Overview
- 4.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Pharmaceuticals Peptic Ulcer Drugs Product Portfolio
- 4.4.5 Teva Pharmaceuticals Recent Developments
- 4.5 EA Pharma
- 4.5.1 EA Pharma Company Information
- 4.5.2 EA Pharma Business Overview
- 4.5.3 EA Pharma Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 EA Pharma Peptic Ulcer Drugs Product Portfolio
- 4.5.5 EA Pharma Recent Developments
- 4.6 ASK Pharm
- 4.6.1 ASK Pharm Company Information
- 4.6.2 ASK Pharm Business Overview
- 4.6.3 ASK Pharm Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ASK Pharm Peptic Ulcer Drugs Product Portfolio
- 4.6.5 ASK Pharm Recent Developments
- 4.7 Luoxin Pharmaceutical
- 4.7.1 Luoxin Pharmaceutical Company Information
- 4.7.2 Luoxin Pharmaceutical Business Overview
- 4.7.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Luoxin Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 4.7.5 Luoxin Pharmaceutical Recent Developments
- 4.8 Abbott Laboratories
- 4.8.1 Abbott Laboratories Company Information
- 4.8.2 Abbott Laboratories Business Overview
- 4.8.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Abbott Laboratories Peptic Ulcer Drugs Product Portfolio
- 4.8.5 Abbott Laboratories Recent Developments
- 4.9 Yuhan Pharmaceutical
- 4.9.1 Yuhan Pharmaceutical Company Information
- 4.9.2 Yuhan Pharmaceutical Business Overview
- 4.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yuhan Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 4.9.5 Yuhan Pharmaceutical Recent Developments
- 4.10 Daewoong Pharmaceutical
- 4.10.1 Daewoong Pharmaceutical Company Information
- 4.10.2 Daewoong Pharmaceutical Business Overview
- 4.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Daewoong Pharmaceutical Peptic Ulcer Drugs Product Portfolio
- 4.10.5 Daewoong Pharmaceutical Recent Developments
5 Global Peptic Ulcer Drugs Market Scenario by Region
- 5.1 Global Peptic Ulcer Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Peptic Ulcer Drugs Sales by Region: 2021-2032
- 5.2.1 Global Peptic Ulcer Drugs Sales by Region: 2021-2026
- 5.2.2 Global Peptic Ulcer Drugs Sales by Region: 2027-2032
- 5.3 Global Peptic Ulcer Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Peptic Ulcer Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Peptic Ulcer Drugs Revenue by Region: 2027-2032
- 5.4 North America Peptic Ulcer Drugs Market Facts & Figures by Country
- 5.4.1 North America Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Peptic Ulcer Drugs Sales by Country (2021-2032)
- 5.4.3 North America Peptic Ulcer Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Peptic Ulcer Drugs Market Facts & Figures by Country
- 5.5.1 Europe Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Peptic Ulcer Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Peptic Ulcer Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Peptic Ulcer Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Peptic Ulcer Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Peptic Ulcer Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Peptic Ulcer Drugs Market Facts & Figures by Country
- 5.7.1 South America Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Peptic Ulcer Drugs Sales by Country (2021-2032)
- 5.7.3 South America Peptic Ulcer Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Peptic Ulcer Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Peptic Ulcer Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Peptic Ulcer Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Peptic Ulcer Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Peptic Ulcer Drugs Sales by Type (2021-2032)
- 6.1.1 Global Peptic Ulcer Drugs Sales by Type (2021-2032) & (M Unit)
- 6.1.2 Global Peptic Ulcer Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Peptic Ulcer Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Peptic Ulcer Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Peptic Ulcer Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Peptic Ulcer Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Peptic Ulcer Drugs Sales by Application (2021-2032)
- 7.1.1 Global Peptic Ulcer Drugs Sales by Application (2021-2032) & (M Unit)
- 7.1.2 Global Peptic Ulcer Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Peptic Ulcer Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Peptic Ulcer Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Peptic Ulcer Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Peptic Ulcer Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Peptic Ulcer Drugs Value Chain Analysis
- 8.1.1 Peptic Ulcer Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Peptic Ulcer Drugs Production Mode & Process
- 8.2 Peptic Ulcer Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Peptic Ulcer Drugs Distributors
- 8.2.3 Peptic Ulcer Drugs Customers
9 Global Peptic Ulcer Drugs Analyzing Market Dynamics
- 9.1 Peptic Ulcer Drugs Industry Trends
- 9.2 Peptic Ulcer Drugs Industry Drivers
- 9.3 Peptic Ulcer Drugs Industry Opportunities and Challenges
- 9.4 Peptic Ulcer Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst